Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer
NCT03677076
·
clinicaltrials.gov ↗
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
OTHER:
Ancillary/Correlative
Sponsor
Medical University of South Carolina